Silver Book Fact

A meta-analysis of clinical trials found that Vitamin D supplements reduced the risk of vertebral fractures by around 37%.

Papadimitropoulos, Emmanuel, George Wells, Beverley Shea, William Gillespie, Bruce Weaver, Nicole Zytaruk, Ann Cranney, Jonathan D. Adachi, Peter Tugwell, Robert Josse, Carol Greenwood, and Gordon Guyatt. VIII: Meta-Analysis of the Efficacy of Vitamin D Treatment in Preventing Osteoporosis in Postmenopausal Women. Endocr Rev. 2002; 23(4): 560-9. http://edrv.endojournals.org/cgi/content/full/23/4/560

Reference

Title
VIII: Meta-Analysis of the Efficacy of Vitamin D Treatment in Preventing Osteoporosis in Postmenopausal Women
Publication
Endocr Rev
Publication Date
2002
Authors
Papadimitropoulos, Emmanuel, George Wells, Beverley Shea, William Gillespie, Bruce Weaver, Nicole Zytaruk, Ann Cranney, Jonathan D. Adachi, Peter Tugwell, Robert Josse, Carol Greenwood, and Gordon Guyatt
Volume & Issue
Volume 23, Issue 4
Pages
560-9
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Raloxifene, a selective estrogen receptor modulator (SERM), has been shown to decrease vertebral fractures by up to 50% after 3 years.  
  • A study of a number of osteoporosis treatments found cost-effectiveness ratios as low as $55,000 per QALY.  
  • A meta-analysis of clinical trials found that Vitamin D supplements reduced the risk of vertebral fractures by around 37%.  
  • Raloxifene, a selective estrogen receptor modulator (SERM) has been shown to increase vertebral bone mineral density (BMD) by 2% to 3% after 3 years.  
  • Treatment with zoledronic acid over a 3-year period reduced risk of vertebral fracture by around 70% and risk of hip fracture by 41%, and increased bone mineral density (BMD) by…